Maliheh Davari: Exploring CRISPR Activation for Hemophilia at ISTH 2026
Maliheh Davari, Postdoctoral Fellow at Queen’s University, shared a post on LinkedIn:
“I am thrilled to announce that I had the opportunity to present my study, ‘Targeted CRISPRa-Mediated Enhancement of Inverted F8 Exon 1–22 Fragment Expression in Hemophilic Canine Endothelial Cells’, at the International Society on Thrombosis and Haemostasis (ISTH) 2026 Congress in Paris.
It was a great privilege to share our work with researchers and clinicians from around the world and to engage in valuable scientific discussions.
I would like to express my sincere gratitude to my supervisor, Dr. David Lillicrap, for his invaluable mentorship, continuous guidance, and unwavering support throughout this project.
Presenting at ISTH has been an enriching experience, and I look forward to continuing this research and contributing to advances in the field of thrombosis and hemostasis.”
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week
-
Nov 8, 2026, 14:55Andra T.: Antiphospholipid Syndrome and Its Thrombotic Risks
-
Nov 8, 2026, 14:06Shayan Mohammadmoradi: ZEUS Trial-Inflammation Reduction Without Fewer Cardiovascular Events
-
Nov 8, 2026, 14:05Kausik Ray: Plaque-Guided Care for Better Coronary Outcomes
-
Nov 8, 2026, 14:05Athira Elssa Johnson: Understanding Coronary Thrombosis and Its Risks
-
Nov 8, 2026, 14:04Sanjiv Beri: Blood Type Compatibility and the Balance of Giving and Receiving
-
Nov 8, 2026, 14:02Gabriela Hobbs: Recognizing Outstanding Abstract Achievements-ASH 2026
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics